logo
Biomarker screening for cardiac dysfunction
Current status of the total artificial heart
The 12-lead electrocardiogram as a predictive tool of mortality after acute myocardial infarction
Heparin-induced thrombocytopenia and cardiovascular diseases
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus
Statin use in heart failure
Evaluation of diagnostic imaging technologies and therapeutics devices
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension
Intravascular ultrasound assessment of novel antiatherosclerotic therapies
Clinical, imaging, and pathological characteristics of left ventricular thrombus
Effect of teaching and type of stethoscope on cardiac auscultatory performance
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure
Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy
Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure
Ischemic stroke after heart failure
Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non–ST-segment elevation acute coronary syndromes
The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction
Recombinant P-selectin glycoprotein ligand–immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial
Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study
Estradiol increases platelet aggregation in PlA1/A1 individuals
The obesity paradox in non–ST-segment elevation acute coronary syndromes
Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention
Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block
The effect of patient sex on recurrence of atrial fibrillation following successful direct current cardioversion
Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements
Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention
Borderline left ventricles in prenatally diagnosed atrioventricular septal defect or double outlet right ventricle
Persistence and adherence to cholesterol lowering agents
Conjugated equine estrogens and peripheral arterial disease risk
Is alcohol consumption associated with calcified atherosclerotic plaque in the coronary arteries and aorta?
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Circulating endothelial progenitor cells predict coronary artery disease severity
Are elevations of N-terminal probrain natriuretic peptide in endurance athletes after prolonged strenuous exercise due to systemic inflammatory cytokines?
Brain natriuretic peptide (BNP) and exercise-induced immune reactions
A1c and mortality
A1c and mortality
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
What information can an invasive cardiologist obtain from brain natriuretic peptide?
Letter to the Editor
Response to Letter to the Editor